Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cystectomy | 9 | 2019 | 218 | 4.95 | Why? |
| Nephrectomy | 12 | 2021 | 406 | 3.08 | Why? |
| Urinary Bladder Neoplasms | 8 | 2019 | 614 | 2.46 | Why? |
| Prostatectomy | 6 | 2019 | 485 | 2.43 | Why? |
| Carcinoma, Renal Cell | 10 | 2021 | 545 | 1.83 | Why? |
| Kidney Neoplasms | 14 | 2021 | 832 | 1.79 | Why? |
| Prostatic Neoplasms | 10 | 2020 | 1637 | 1.72 | Why? |
| Urinary Diversion | 3 | 2018 | 26 | 1.51 | Why? |
| Urologic Surgical Procedures | 11 | 2021 | 996 | 1.44 | Why? |
| Renal Artery | 2 | 2018 | 66 | 1.30 | Why? |
| Robotics | 5 | 2018 | 528 | 1.23 | Why? |
| Urinary Bladder | 3 | 2018 | 170 | 1.19 | Why? |
| Urinary Incontinence | 3 | 2020 | 148 | 1.14 | Why? |
| Urinary Reservoirs, Continent | 2 | 2018 | 11 | 0.95 | Why? |
| Prostate | 3 | 2021 | 283 | 0.94 | Why? |
| Prostatic Hyperplasia | 3 | 2018 | 161 | 0.93 | Why? |
| Recovery of Function | 6 | 2019 | 2461 | 0.92 | Why? |
| Image-Guided Biopsy | 2 | 2018 | 185 | 0.82 | Why? |
| Urology | 6 | 2021 | 1685 | 0.73 | Why? |
| Perioperative Care | 3 | 2020 | 1329 | 0.72 | Why? |
| Urinary Catheterization | 1 | 2018 | 47 | 0.72 | Why? |
| Parenchymal Tissue | 1 | 2018 | 61 | 0.70 | Why? |
| Cystitis | 1 | 2018 | 45 | 0.70 | Why? |
| Lower Urinary Tract Symptoms | 2 | 2018 | 116 | 0.70 | Why? |
| Surgical Instruments | 1 | 2018 | 145 | 0.69 | Why? |
| Robotic Surgical Procedures | 6 | 2019 | 787 | 0.69 | Why? |
| Suture Techniques | 1 | 2018 | 138 | 0.66 | Why? |
| Androgen Antagonists | 2 | 2018 | 404 | 0.65 | Why? |
| Neoplasm Recurrence, Local | 4 | 2018 | 1063 | 0.65 | Why? |
| Kidney | 5 | 2018 | 3648 | 0.64 | Why? |
| Ileum | 1 | 2018 | 233 | 0.63 | Why? |
| Cadaver | 2 | 2018 | 626 | 0.62 | Why? |
| Laparoscopy | 7 | 2020 | 1532 | 0.57 | Why? |
| Warm Ischemia | 4 | 2018 | 33 | 0.56 | Why? |
| Terminology as Topic | 1 | 2018 | 546 | 0.51 | Why? |
| Carcinoma, Transitional Cell | 4 | 2018 | 198 | 0.50 | Why? |
| Blood Loss, Surgical | 4 | 2018 | 211 | 0.48 | Why? |
| Intestines | 1 | 2018 | 817 | 0.45 | Why? |
| Operative Time | 3 | 2018 | 450 | 0.43 | Why? |
| Minimally Invasive Surgical Procedures | 5 | 2020 | 663 | 0.42 | Why? |
| Surgery, Computer-Assisted | 1 | 2012 | 183 | 0.40 | Why? |
| Urologists | 3 | 2021 | 447 | 0.33 | Why? |
| Referral and Consultation | 2 | 2020 | 4816 | 0.33 | Why? |
| Plant Extracts | 1 | 2018 | 1514 | 0.32 | Why? |
| Magnetic Resonance Imaging | 3 | 2018 | 6551 | 0.29 | Why? |
| Early Detection of Cancer | 1 | 2017 | 1956 | 0.28 | Why? |
| Urologic Neoplasms | 3 | 2020 | 348 | 0.27 | Why? |
| Urologic Diseases | 3 | 2020 | 860 | 0.26 | Why? |
| Treatment Outcome | 16 | 2019 | 51732 | 0.24 | Why? |
| Digital Rectal Examination | 1 | 2021 | 19 | 0.23 | Why? |
| Aging | 1 | 2017 | 3581 | 0.22 | Why? |
| Humans | 55 | 2021 | 930598 | 0.20 | Why? |
| Male | 33 | 2021 | 367725 | 0.20 | Why? |
| Biopsy | 2 | 2021 | 2811 | 0.20 | Why? |
| Seminal Vesicles | 1 | 2019 | 12 | 0.20 | Why? |
| Tumor Burden | 2 | 2013 | 369 | 0.20 | Why? |
| Serenoa | 1 | 2018 | 3 | 0.19 | Why? |
| Learning Curve | 1 | 2020 | 157 | 0.19 | Why? |
| Cold Ischemia | 1 | 2018 | 37 | 0.19 | Why? |
| Postoperative Period | 2 | 2018 | 651 | 0.18 | Why? |
| Organ Sparing Treatments | 1 | 2018 | 91 | 0.18 | Why? |
| Postoperative Complications | 6 | 2019 | 5861 | 0.18 | Why? |
| Defecation | 1 | 2018 | 38 | 0.18 | Why? |
| Vena Cava, Inferior | 1 | 2019 | 103 | 0.18 | Why? |
| Chyle | 1 | 2017 | 1 | 0.18 | Why? |
| Ureteral Obstruction | 1 | 2018 | 61 | 0.17 | Why? |
| Pelvic Organ Prolapse | 2 | 2020 | 71 | 0.17 | Why? |
| Constriction, Pathologic | 1 | 2018 | 212 | 0.17 | Why? |
| Chi-Square Distribution | 2 | 2012 | 961 | 0.17 | Why? |
| Magnetic Resonance Imaging, Interventional | 1 | 2017 | 38 | 0.17 | Why? |
| Indazoles | 1 | 2017 | 77 | 0.17 | Why? |
| Neoplasm Staging | 5 | 2011 | 1999 | 0.16 | Why? |
| Italy | 8 | 2020 | 38444 | 0.16 | Why? |
| Lymphatic Diseases | 1 | 2017 | 96 | 0.16 | Why? |
| Phenylurea Compounds | 1 | 2017 | 101 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.16 | Why? |
| Smoke | 1 | 2020 | 349 | 0.15 | Why? |
| Intraoperative Complications | 1 | 2018 | 221 | 0.15 | Why? |
| Imaging, Three-Dimensional | 2 | 2018 | 680 | 0.15 | Why? |
| Papillomaviridae | 1 | 2020 | 404 | 0.15 | Why? |
| Bevacizumab | 1 | 2017 | 149 | 0.15 | Why? |
| Niacinamide | 1 | 2017 | 135 | 0.15 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.15 | Why? |
| Glomerular Filtration Rate | 2 | 2018 | 1262 | 0.15 | Why? |
| Dissection | 1 | 2017 | 164 | 0.15 | Why? |
| Pandemics | 12 | 2021 | 389249 | 0.14 | Why? |
| Aged | 20 | 2018 | 215776 | 0.14 | Why? |
| Prostate-Specific Antigen | 1 | 2015 | 213 | 0.14 | Why? |
| Telecommunications | 1 | 2020 | 551 | 0.13 | Why? |
| Pyrroles | 1 | 2017 | 292 | 0.13 | Why? |
| Antineoplastic Agents, Hormonal | 1 | 2015 | 203 | 0.13 | Why? |
| Time Factors | 6 | 2018 | 31397 | 0.13 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 3 | 2021 | 9706 | 0.13 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.13 | Why? |
| Quality of Life | 2 | 2017 | 9820 | 0.12 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.12 | Why? |
| Predictive Value of Tests | 5 | 2018 | 9537 | 0.12 | Why? |
| Hepatitis B virus | 1 | 2020 | 882 | 0.12 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2017 | 604 | 0.12 | Why? |
| Life Expectancy | 1 | 2017 | 474 | 0.12 | Why? |
| Standard of Care | 1 | 2019 | 1297 | 0.12 | Why? |
| Imidazoles | 1 | 2017 | 631 | 0.11 | Why? |
| Phytotherapy | 1 | 2018 | 743 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Observational Studies as Topic | 1 | 2018 | 1887 | 0.10 | Why? |
| Renal Insufficiency | 1 | 2017 | 810 | 0.10 | Why? |
| Risk Factors | 8 | 2018 | 71621 | 0.10 | Why? |
| Congresses as Topic | 1 | 2020 | 1347 | 0.10 | Why? |
| Aged, 80 and over | 9 | 2018 | 88759 | 0.10 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.10 | Why? |
| Anesthesiology | 1 | 2020 | 1163 | 0.10 | Why? |
| Prospective Studies | 5 | 2018 | 43301 | 0.09 | Why? |
| Pyrimidines | 1 | 2017 | 1557 | 0.09 | Why? |
| Survival Rate | 3 | 2021 | 9206 | 0.09 | Why? |
| Blood Transfusion | 1 | 2018 | 1399 | 0.09 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2018 | 1458 | 0.09 | Why? |
| Indoles | 1 | 2017 | 1243 | 0.09 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.09 | Why? |
| Immunization Programs | 1 | 2021 | 2006 | 0.09 | Why? |
| Female | 19 | 2021 | 380317 | 0.09 | Why? |
| Sulfonamides | 1 | 2017 | 1294 | 0.09 | Why? |
| Middle Aged | 15 | 2018 | 270681 | 0.09 | Why? |
| Survival Analysis | 3 | 2017 | 7592 | 0.08 | Why? |
| Clinical Protocols | 1 | 2018 | 2734 | 0.08 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.07 | Why? |
| Kidney Diseases | 1 | 2017 | 1434 | 0.07 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
| MicroRNAs | 1 | 2018 | 1787 | 0.07 | Why? |
| Cell Nucleus | 1 | 2007 | 399 | 0.07 | Why? |
| Time-to-Treatment | 1 | 2021 | 5883 | 0.07 | Why? |
| Disease-Free Survival | 1 | 2009 | 1654 | 0.07 | Why? |
| Venous Thrombosis | 1 | 2019 | 2739 | 0.06 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.06 | Why? |
| Guideline Adherence | 1 | 2015 | 2309 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.06 | Why? |
| Surveys and Questionnaires | 1 | 2009 | 43792 | 0.06 | Why? |
| Retrospective Studies | 7 | 2018 | 105322 | 0.06 | Why? |
| Nomograms | 1 | 2007 | 790 | 0.05 | Why? |
| Disease Progression | 4 | 2018 | 13580 | 0.05 | Why? |
| Papilloma | 1 | 2020 | 37 | 0.05 | Why? |
| Lymph Nodes | 1 | 2007 | 1060 | 0.05 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.05 | Why? |
| Condylomata Acuminata | 1 | 2020 | 62 | 0.05 | Why? |
| Odds Ratio | 1 | 2012 | 5861 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Warts | 1 | 2020 | 59 | 0.05 | Why? |
| Urinary Calculi | 1 | 2020 | 80 | 0.05 | Why? |
| Corrosion Casting | 1 | 2018 | 1 | 0.05 | Why? |
| Kidney Cortex | 1 | 2018 | 11 | 0.05 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.05 | Why? |
| Internship and Residency | 1 | 2020 | 4987 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Evidence-Based Medicine | 1 | 2012 | 3228 | 0.05 | Why? |
| Gastrectomy | 1 | 2020 | 225 | 0.05 | Why? |
| Hematuria | 1 | 2020 | 284 | 0.05 | Why? |
| Cytoreduction Surgical Procedures | 1 | 2019 | 144 | 0.05 | Why? |
| Margins of Excision | 1 | 2018 | 122 | 0.04 | Why? |
| Neoplasm, Residual | 1 | 2018 | 147 | 0.04 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.04 | Why? |
| Risk | 2 | 2021 | 5288 | 0.04 | Why? |
| Practice Guidelines as Topic | 2 | 2020 | 15421 | 0.04 | Why? |
| Laryngeal Neoplasms | 1 | 2020 | 202 | 0.04 | Why? |
| Age Factors | 2 | 2017 | 21039 | 0.04 | Why? |
| Biomarkers | 2 | 2018 | 23361 | 0.04 | Why? |
| Kidney Pelvis | 1 | 2017 | 22 | 0.04 | Why? |
| Prognosis | 3 | 2018 | 32490 | 0.04 | Why? |
| Health Surveys | 1 | 2009 | 2841 | 0.04 | Why? |
| Risk Assessment | 4 | 2018 | 25439 | 0.04 | Why? |
| Retroperitoneal Space | 1 | 2017 | 68 | 0.04 | Why? |
| Rupture, Spontaneous | 1 | 2017 | 115 | 0.04 | Why? |
| Hepatectomy | 1 | 2020 | 276 | 0.04 | Why? |
| Colectomy | 1 | 2020 | 327 | 0.04 | Why? |
| Minnesota | 1 | 2018 | 509 | 0.04 | Why? |
| Emotions | 1 | 2009 | 2418 | 0.04 | Why? |
| Inventions | 1 | 2020 | 372 | 0.04 | Why? |
| Forecasting | 2 | 2020 | 4492 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.04 | Why? |
| Neoplasm Metastasis | 1 | 2018 | 682 | 0.03 | Why? |
| Urinary Tract Infections | 1 | 2020 | 534 | 0.03 | Why? |
| Urine | 1 | 2017 | 469 | 0.03 | Why? |
| Prescriptions | 1 | 2015 | 258 | 0.03 | Why? |
| Combined Modality Therapy | 2 | 2015 | 3395 | 0.03 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.03 | Why? |
| Sacrum | 1 | 2013 | 41 | 0.03 | Why? |
| Radiopharmaceuticals | 1 | 2018 | 763 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Telemedicine | 2 | 2020 | 25032 | 0.03 | Why? |
| Papillomavirus Infections | 1 | 2020 | 861 | 0.03 | Why? |
| Teaching | 1 | 2020 | 1208 | 0.03 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2018 | 1153 | 0.03 | Why? |
| Vagina | 1 | 2013 | 327 | 0.03 | Why? |
| Follow-Up Studies | 3 | 2017 | 17020 | 0.03 | Why? |
| Europe | 2 | 2020 | 12702 | 0.02 | Why? |
| Young Adult | 2 | 2018 | 93724 | 0.02 | Why? |
| Gynecologic Surgical Procedures | 1 | 2013 | 489 | 0.02 | Why? |
| Chemotherapy, Adjuvant | 1 | 2010 | 606 | 0.02 | Why? |
| North America | 1 | 2011 | 1400 | 0.02 | Why? |
| Decision Making | 1 | 2020 | 3132 | 0.02 | Why? |
| Lymphatic Metastasis | 1 | 2007 | 537 | 0.02 | Why? |
| Asia | 1 | 2011 | 2399 | 0.02 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.02 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.02 | Why? |
| Elective Surgical Procedures | 1 | 2020 | 5338 | 0.01 | Why? |
| Patient Selection | 1 | 2015 | 4560 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.01 | Why? |
| Multivariate Analysis | 1 | 2007 | 5440 | 0.01 | Why? |
| Cohort Studies | 2 | 2010 | 36005 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| Adult | 4 | 2018 | 244371 | 0.01 | Why? |
| Logistic Models | 1 | 2007 | 9089 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2015 | 53120 | 0.01 | Why? |
| Child | 1 | 2007 | 70012 | 0.00 | Why? |
| Adolescent | 1 | 2007 | 86841 | 0.00 | Why? |
Ficarra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(220)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(69)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_